日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Occupational exposure to pesticides deregulates systemic cortisol levels in women with breast cancer and correlates with poor prognosis features

职业性接触农药会扰乱乳腺癌女性体内皮质醇的全身水平,并与不良预后特征相关。

Jumes, J J; Jaques, H S; Dalla Vecchia, M F; Ferreira, M O; Orrutéa, J F G; Machado, M G; Mezoni, M F; Silva, R G S da; Almeida, R F; Rech, D; Kawassaki, A C B; Panis, C

Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Through Week 96 from IMPAACT 2014

多拉韦林/拉米夫定/富马酸替诺福韦酯固定剂量复方片剂在感染 HIV 的青少年中的疗效、安全性和耐受性:IMPAACT 2014 研究中截至第 96 周的结果

Rungmaitree, Supattra; Aurpibul, Linda; Best, Brookie M; Li, Xiang; Warshaw, Meredith G; Wan, Hong; Tobin, Nicole H; Jumes, Patricia; Leavitt, Randi; McCarthy, Katie; Scheckter, Rachel; Ounchanum, Pradthana; Violari, Avy; Teppler, Hedy; Campbell, Havilland; Krotje, Chelsea; Townley, Ellen; Moye, Jack; Melvin, Ann J

Pharmacokinetic Interactions between the Hepatitis C Virus Inhibitors Elbasvir and Grazoprevir and HIV Protease Inhibitors Ritonavir, Atazanavir, Lopinavir, and Darunavir in Healthy Volunteers

在健康志愿者中,丙型肝炎病毒抑制剂艾尔巴韦和格拉佐普韦与HIV蛋白酶抑制剂利托那韦、阿扎那韦、洛匹那韦和达芦那韦之间的药代动力学相互作用

Feng, Hwa-Ping; Caro, Luzelena; Fandozzi, Christine; Chu, Xiaoyan; Guo, Zifang; Talaty, Jennifer; Panebianco, Deborah; Dunnington, Katherine; Du, Lihong; Hanley, William D; Fraser, Iain P; Mitselos, Anna; Denef, Jean-Francois; De Lepeleire, Inge; de Hoon, Jan N; Vandermeulen, Corinne; Marshall, William L; Jumes, Patricia; Huang, Xiaobi; Martinho, Monika; Valesky, Robert; Butterton, Joan R; Iwamoto, Marian; Yeh, Wendy W

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects

瑞来巴坦(一种新型β-内酰胺酶抑制剂)与亚胺培南-西司他丁联合用药在健康受试者中的肺内药代动力学研究

Rizk, Matthew L; Rhee, Elizabeth G; Jumes, Patricia A; Gotfried, Mark H; Zhao, Tian; Mangin, Eric; Bi, Sheng; Chavez-Eng, Cynthia M; Zhang, Zufei; Butterton, Joan R

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants

在健康受试者中,单次和多次服用β-内酰胺酶抑制剂瑞巴坦联合亚胺培南和西司他丁的药代动力学、安全性和耐受性研究

Rhee, Elizabeth G; Rizk, Matthew L; Calder, Nicole; Nefliu, Marcela; Warrington, Steven J; Schwartz, Michael S; Mangin, Eric; Boundy, Keith; Bhagunde, Pratik; Colon-Gonzalez, Francheska; Jumes, Patricia; Liu, Yang; Butterton, Joan R

Erratum for Rhee et al., "Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants"

Rhee 等人的论文“健康受试者单次和多次服用 β-内酰胺酶抑制剂 Relebactam 与亚胺培南和西司他丁联合用药的药代动力学、安全性和耐受性”的勘误

Rhee, Elizabeth G; Rizk, Matthew L; Calder, Nicole; Nefliu, Marcela; Warrington, Steven J; Schwartz, Michael S; Mangin, Eric; Boundy, Keith; Bhagunde, Pratik; Colon-Gonzalez, Francheska; Jumes, Patricia; Liu, Yang; Butterton, Joan R

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects

阿那西曲匹抑制CETP(胆固醇酯转移蛋白)可降低轻度高胆固醇血症患者的脂蛋白(a)生成

Thomas, Tiffany; Zhou, Haihong; Karmally, Wahida; Ramakrishnan, Rajasekhar; Holleran, Stephen; Liu, Yang; Jumes, Patricia; Wagner, John A; Hubbard, Brian; Previs, Stephen F; Roddy, Thomas; Johnson-Levonas, Amy O; Gutstein, David E; Marcovina, Santica M; Rader, Daniel J; Ginsberg, Henry N; Millar, John S; Reyes-Soffer, Gissette

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E

使用 anacetrapib 抑制 CETP 对 VLDL-TG 和血浆载脂蛋白 C-II、C-III 和 E 代谢的影响

John S Millar, Michael E Lassman, Tiffany Thomas, Rajasekhar Ramakrishnan, Patricia Jumes, Richard L Dunbar, Emil M deGoma, Amanda L Baer, Wahida Karmally, Daniel S Donovan, Hashmi Rafeek, John A Wagner, Stephen Holleran, Joseph Obunike, Yang Liu, Soumia Aoujil, Taylor Standiford, David E Gutstein, 

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects

阿那曲匹可通过增加轻度高胆固醇血症患者的载脂蛋白B清除率来降低低密度脂蛋白胆固醇(LDL-C)水平。

Millar, John S; Reyes-Soffer, Gissette; Jumes, Patricia; Dunbar, Richard L; deGoma, Emil M; Baer, Amanda L; Karmally, Wahida; Donovan, Daniel S; Rafeek, Hashmi; Pollan, Laura; Tohyama, Junichiro; Johnson-Levonas, Amy O; Wagner, John A; Holleran, Stephen; Obunike, Joseph; Liu, Yang; Ramakrishnan, Rajasekhar; Lassman, Michael E; Gutstein, David E; Ginsberg, Henry N; Rader, Daniel J

Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein

阿那西曲匹抑制胆固醇酯转移蛋白可降低高密度脂蛋白载脂蛋白AI和血浆胆固醇酯转移蛋白的分数清除率。

Reyes-Soffer, Gissette; Millar, John S; Ngai, Colleen; Jumes, Patricia; Coromilas, Ellie; Asztalos, Bela; Johnson-Levonas, Amy O; Wagner, John A; Donovan, Daniel S; Karmally, Wahida; Ramakrishnan, Rajasekhar; Holleran, Stephen; Thomas, Tiffany; Dunbar, Richard L; deGoma, Emil M; Rafeek, Hashmi; Baer, Amanda L; Liu, Yang; Lassman, Michael E; Gutstein, David E; Rader, Daniel J; Ginsberg, Henry N